Mesenchymal stem cells: No longer second class marrow citizens

被引：116
作者：
Gerson, SL [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Ireland Canc Ctr, Div Hematol Oncol, Cleveland, OH 44106 USA
来源：
NATURE MEDICINE | 1999年 / 5卷 / 03期
关键词：
D O I：
10.1038/6470
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Osteogenesis Imperfeca study raises new hopes and questions for mesenchymal and stem cell therapies (pages 309–313).
引用
收藏
页码：262 / 264
页数：3
相关论文
共 16 条
  • [1] LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
    Allay, JA
    Dennis, JE
    Haynesworth, SE
    Majumdar, MK
    Clapp, DW
    Shultz, LD
    Caplan, AI
    Gerson, SL
    [J]. HUMAN GENE THERAPY, 1997, 8 (12) : 1417 - 1427
  • [2] Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
  • [3] 2-F
  • [4] CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
  • [5] CONSTANTINOU CD, 1990, AM J HUM GENET, V47, P670
  • [6] CELL-SURFACE ANTIGENS ON HUMAN MARROW-DERIVED MESENCHYMAL CELLS ARE DETECTED BY MONOCLONAL-ANTIBODIES
    HAYNESWORTH, SE
    BABER, MA
    CAPLAN, AI
    [J]. BONE, 1992, 13 (01) : 69 - 80
  • [7] Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
    Horwitz, EM
    Prockop, DJ
    Fitzpatrick, LA
    Koo, WWK
    Gordon, PL
    Neel, M
    Sussman, M
    Orchard, P
    Marx, JC
    Pyeritz, RE
    Brenner, MK
    [J]. NATURE MEDICINE, 1999, 5 (03) : 309 - 313
  • [8] Koç ON, 1998, BLOOD, V92, p274A
  • [9] LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557
  • [10] MAJUMDAR MK, 1998, J CELL PHYSL, V176, P186
12